Explore the full directors' dealings record of EMEIS, a publicly traded company based in France. Shares are quoted on FR FR, under the supervision of AMF. Operating in the Healthcare & Pharma sector, EMEIS has recorded 20 public disclosures. Market capitalisation: €2.4bn. The latest transaction was disclosed on 2 August 2024 — Exercice de bons de souscription d'actions. Among the most active insiders: CAISSE DES DEPOTS ET CONSIGNATIONS Etablissement Public. The full history is free.
FY ended December 2025 · cache
0 of 0 declarations
emeis is a major European healthcare and care-services group focused on supporting vulnerable people. Listed on Euronext Paris under ISIN FR001400NLM4, the company is the renamed successor of Orpea, which adopted the emeis identity in March 2024 to signal the opening of a new chapter in its corporate history. In June 2025, the group took another important step by becoming a mission-driven company, embedding four statutory commitments: changing perceptions of vulnerable people and their families, improving the recognition and attractiveness of its professions, strengthening local social cohesion, and innovating to deliver care that is more respectful of the planet and living beings. This evolution reflects a broader effort to rebuild trust, reshape governance and reinforce the company’s long-term social purpose. Historically, the group built its business around long-term care for elderly people before expanding into a wider range of health and support services. Today, emeis operates across five core areas of expertise: psychiatric clinics, medical and rehabilitation clinics, nursing homes, home care and support services, and assisted living facilities. Each year, the group welcomes nearly 280,000 residents, patients and beneficiaries, supported by around 83,500 professionals working in care, hospitality and support functions. This scale gives emeis meaningful operational depth in a sector where quality of service, local presence and clinical expertise are essential competitive factors. emeis has a broad international footprint. The group is present in around 20 countries across Europe and beyond, including France, Germany, Belgium, Spain, Italy, Portugal, Switzerland, the United Kingdom, Central Europe, Latin America and China. Its network comprises more than 1,000 facilities and more than 50 brands, each anchored in local markets. This diversified geographic base helps emeis address structural demand drivers such as population ageing, rising mental-health needs and the increasing need for rehabilitation and long-duration care. From an equity-market perspective, emeis is controlled 50.3% by Caisse des Dépôts, CNP Assurances, MAIF and MACSF Epargne Retraite, and is included in the SBF 120, CAC Mid 60 and CAC All-Tradable indices. The group has also been actively reshaping its asset portfolio, pursuing targeted disposals to strengthen its balance sheet and improve financial flexibility. Its 2025 results, published in April 2026, showed a strong improvement in operating performance and margins, supporting the view that the turnaround is gaining traction. Overall, emeis stands out as a large-scale European care platform in transition, combining essential healthcare services, a wide geographic reach and a renewed strategic focus on sustainable, people-centered growth.